US2008004613A1PendingUtilityA1

Methods and devices for treatment of migraines

Assignee: BENECHILL INCPriority: May 13, 2005Filed: Jul 24, 2007Published: Jan 3, 2008
Est. expiryMay 13, 2025(expired)· nominal 20-yr term from priority
A61M 11/02A61M 15/08A61M 16/04A61M 19/00A61M 15/085A61K 31/02A61M 16/0461A61M 16/107A61F 2007/0065A61M 16/209A61M 25/007A61P 43/00A61M 16/0409A61M 25/1011A61M 2025/0036A61M 25/0068A61M 16/0459A61M 16/0479A61M 16/0486A61M 25/0032A61M 2202/0275A61M 2016/0027A61F 7/12A61M 16/06A61M 2025/0073A61M 16/0443A61F 7/123A61M 25/003A61M 2025/0034A61M 11/06A61M 16/0438A61M 2205/3606A61M 31/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for treating a migraine by cooling a patient's nasopharyngeal cavity are described. In one method, a cooling assembly is inserted into a nasal cavity through a patient's nostril. The cooling assembly includes a flexible balloon defining a chamber and a first elongate tubular member having a lumen in fluid communication with the chamber. A liquid having a temperature between about −20° C. and about 37° C. is infused through the lumen of the first elongate tubular member into the chamber, wherein the flexible balloon expands to place it in contact with the nasal cavity. In another method, an elongate member having a plurality of ports is inserted into the nasal cavity. A perfluorocarbon spray and a gas are then delivered onto a surface of the nasal cavity through the plurality of ports.

Claims

exact text as granted — not AI-modified
1 .- 32 . (canceled)  
     
     
         33 . A method for treating a migraine, comprising the steps of: 
 selecting a patient suffering from a migraine; and    cooling the patient's nasopharyngeal cavity to treat the migraine.    
     
     
         34 . The method of  claim 33 , further comprising the step of delivering a drug to the patient.  
     
     
         35 . The method of  claim 34 , wherein the drug is delivered onto a surface of the patient's nasal cavity.  
     
     
         36 . The method of  claim 34 , wherein the drug is sumatriptan.  
     
     
         37 .- 51 . (canceled)

Join the waitlist — get patent alerts

Track US2008004613A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.